ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 644

Seroprevalence and Its Impact on Radiographic Damage in Korean Rheumatoid Arthritis Patients Starting Biologics

Kichul Shin1, Seongjun Ha2, Inkyung Jung3, Hyoun-Ah Kim4 and Shin-Seok Lee5, 1Kyungnam villa #102, Division of Rheumatology, Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea, Republic of, 2Division of Rheumatology, Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea, The Republic of, 3Department of Biostatistics, Yonsei University College of Medicine, Seoul, Korea, The Republic of, 4Ajou University Hospital, Suwon, South Korea, 5Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, The Republic of

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: anti-CCP antibodies, Biologics, joint damage and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Sunday, November 13, 2016

Session Title: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: High titers of rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (ACCP) are poor prognostic factors for rheumatoid arthritis (RA) patients. Only few studies have investigated the detailed clinical subtypes or radiographic changes based on serologic status; double (RF/ACCP) positive (+ve), RF or ACCP +ve, double negative (-ve) (seronegative, SN). We aimed to analyze the clinical and radiographic features of RA patients with robust disease activity, based on their serologic status.

Methods: RA patients registered in the Korean College of Rheumatology Biologics Registry (KOBIO), a nationwide inception cohort, were analyzed. Data regarding patient demographics, comorbidity, disease activity, medication, imaging and laboratory exams were utilized. After adjusting for gender, age, disease duration, and smoking history, we analyzed the association of seropositivity and bony erosion (hands and feet X-ray), and the association of the ACCP titer and joint damage, both at baseline (initiation of biologics) presented as odd ratio (OR) and its 95% confidence interval [95% CI].

Results: Data of 1198 RA patients were investigated. Mean age was 57.2 years, and disease duration was 8.3 +/- 7.6 years. Mean DAS28-ESR was 5.71, and erosion were found in 40.1% of patients. Being ACCP+ve was significantly associated with bony erosions (OR 1.69 [95% CI 1.13-2.52], p= 0.0096), compared with RF+ve (OR 1.03 p= 0.83), or RF+ve/ACCP+ve (OR 2.19 [95% CI 1.19-4.01], p= 0.012). Of note, being ACCP+ve/RF-ve was strongly associated with radiographic damage (OR 4.93 [95% CI 2.29-10.61], p< 0.0001) in our analysis (figure). In contrast, a multivariate logistic regression analysis showed that baseline ACCP titers were not positively associated with joint damage; a multivariate linear regression model revealed disease duration (estimate -3.95, p< 0.0001) and RF titer (estimate +0.0665, p= 0.0157) were associated with ACCP titers.

Conclusion: Our data demonstrate the significance of ACCP in predicting radiographic damage in established Korean RA patients with persistently high disease activity. Longitudinal studies would be needed to clarify the impact of ACCP titers on radiographic progression.


Disclosure: K. Shin, None; S. Ha, None; I. Jung, None; H. A. Kim, None; S. S. Lee, None.

To cite this abstract in AMA style:

Shin K, Ha S, Jung I, Kim HA, Lee SS. Seroprevalence and Its Impact on Radiographic Damage in Korean Rheumatoid Arthritis Patients Starting Biologics [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/seroprevalence-and-its-impact-on-radiographic-damage-in-korean-rheumatoid-arthritis-patients-starting-biologics/. Accessed January 27, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/seroprevalence-and-its-impact-on-radiographic-damage-in-korean-rheumatoid-arthritis-patients-starting-biologics/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.